![Paul Castella](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Castella
Gründer bei Aeon Bioscience, Inc.
Aktive Positionen von Paul Castella
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aeon Bioscience, Inc.
![]() Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Gründer | 08.04.2011 | - |
Corporate Officer/Principal | 29.01.2007 | - | |
Incyte Venture Partners LLC
![]() Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | Chief Investment Officer | 01.03.2013 | - |
Private-Equity-Analyst | 01.03.2013 | - | |
Private Equity Investor | 01.03.2013 | - | |
Präsident | 21.08.2013 | - | |
Bio2 Medical, Inc.
![]() Bio2 Medical, Inc. Pharmaceuticals: MajorHealth Technology BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO. | Direktor/Vorstandsmitglied | 01.12.2006 | - |
Gründer | 01.12.2006 | - | |
Finanzdirektor/CFO | 01.12.2006 | 28.03.2012 | |
StemBioSys, Inc.
![]() StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | - | - |
BioDtech, Inc.
![]() BioDtech, Inc. BiotechnologyHealth Technology BioDtech, Inc. enagages in the development and marketing of products for the detection, neutralization, and removal of endotoxin. It serves the bioresearch and bioprocess markets. The company was founded by Ira Weiss and Michael G. Pepe in September 2003 and is headquartered in Birmingham, AL. | Vorsitzender | - | - |
Innovative Trauma Care, Inc.
![]() Innovative Trauma Care, Inc. Medical SpecialtiesHealth Technology Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | - | - |
CytoBioscience, Inc.
![]() CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | - | - |
Hera Biotech, Inc.
![]() Hera Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Hera Biotech, Inc. is a women's health company based in San Antonio, TX. Hera Biotech is focused on transforming women's health with its revolutionary non-surgical test for early diagnosis and staging of endometriosis, called MetriDx™. The company was founded in 2020 by Paul Castella, Bruce Nicholson, Nameer Kirma, and Somer Baburek, who has been the CEO since incorporation. | Vorsitzender | 01.01.2020 | - |
Gründer | 01.01.2020 | - |
Karriereverlauf von Paul Castella
Ehemalige bekannte Positionen von Paul Castella
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INVENTABIOTECH INC. | Direktor/Vorstandsmitglied | 01.04.2018 | - |
Vorstandsvorsitzender | - | - | |
░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░░ | - | - |
Ausbildung von Paul Castella
The University of Texas at Austin | Masters Business Admin |
University of London | Undergraduate Degree |
Weill Cornell Medical College | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 7 |
Founder | 5 |
Director of Finance/CFO | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 12 |
---|---|
CardioSpectra, Inc.
![]() CardioSpectra, Inc. Medical SpecialtiesHealth Technology CardioSpectra, Inc. manufactures and supplies medical devices. The company specializes in optical imaging, interventional cardiology, medical devices and materials science.It develops products for detection of vulnerable plaque, glaucoma, macular degeneration, diabetic retinopathy and cancer. CardioSpectra was founded by Marc D. Feldman & Thomas Milner in 2005 and is headquartered in San Antonio, TX. | Health Technology |
Aeon Bioscience, Inc.
![]() Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Health Technology |
Incyte Venture Partners LLC
![]() Incyte Venture Partners LLC Investment ManagersFinance Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas. | Finance |
ViroXis Corp.
![]() ViroXis Corp. BiotechnologyHealth Technology ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX. | Health Technology |
Targeted Technology Ventures LLC
![]() Targeted Technology Ventures LLC Miscellaneous Commercial ServicesCommercial Services Targeted Technology Ventures LLC operated as a biotechnology company. The company was founded by Paul Castella and Christopher E Banas and was headquartered in San Antonio, TX. | Commercial Services |
Bio2 Medical, Inc.
![]() Bio2 Medical, Inc. Pharmaceuticals: MajorHealth Technology BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO. | Health Technology |
StemBioSys, Inc.
![]() StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Health Technology |
BioDtech, Inc.
![]() BioDtech, Inc. BiotechnologyHealth Technology BioDtech, Inc. enagages in the development and marketing of products for the detection, neutralization, and removal of endotoxin. It serves the bioresearch and bioprocess markets. The company was founded by Ira Weiss and Michael G. Pepe in September 2003 and is headquartered in Birmingham, AL. | Health Technology |
Innovative Trauma Care, Inc.
![]() Innovative Trauma Care, Inc. Medical SpecialtiesHealth Technology Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX. | Health Technology |
CytoBioscience, Inc.
![]() CytoBioscience, Inc. Medical SpecialtiesHealth Technology CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX. | Health Technology |
InventaBiotech, Inc.
![]() InventaBiotech, Inc. Miscellaneous Commercial ServicesCommercial Services InventaBiotech, Inc. operated as a marketing, media, and investor relations consultant to public and private companies. The company was founded on October 18, 2007 and was headquartered in San Antonio, TX. | Commercial Services |
Hera Biotech, Inc.
![]() Hera Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Hera Biotech, Inc. is a women's health company based in San Antonio, TX. Hera Biotech is focused on transforming women's health with its revolutionary non-surgical test for early diagnosis and staging of endometriosis, called MetriDx™. The company was founded in 2020 by Paul Castella, Bruce Nicholson, Nameer Kirma, and Somer Baburek, who has been the CEO since incorporation. | Commercial Services |
- Börse
- Insiders
- Paul Castella
- Erfahrung